Carcinoembryonic antigen in patients with residual ovarian cancer. Clinical and pathological correlations

Khoo S.K., Whitaker S.V., Jones I.S.C. and Mackay E.V. (1979) Carcinoembryonic antigen in patients with residual ovarian cancer. Clinical and pathological correlations. Gynecologic Oncology, 7 3: 288-295. doi:10.1016/0090-8258(79)90106-9


Author Khoo S.K.
Whitaker S.V.
Jones I.S.C.
Mackay E.V.
Title Carcinoembryonic antigen in patients with residual ovarian cancer. Clinical and pathological correlations
Journal name Gynecologic Oncology   Check publisher's open access policy
ISSN 1095-6859
Publication date 1979
Sub-type Article (original research)
DOI 10.1016/0090-8258(79)90106-9
Volume 7
Issue 3
Start page 288
End page 295
Total pages 8
Subject 2729 Obstetrics and Gynaecology
2730 Oncology
Abstract The level of Carcinoembryonic antigen (CEA) in serum was estimated before the commencement of chemotherapy and/or radiotherapy in 130 patients with residual ovarian cancer. CEA was detected in 64% of the patients. The associated clinical and pathological features were examined. No differences were found in the distribution of patients who were CEA positive and CEA negative in relation to the features studied. However, a correlation between serum CEA levels on one hand and site of tumor, organ involved, and estimated tumor volume on the other was found among the CEA-positive patients. No direct correlation was observed between CEA levels and subsequent behavior of the disease, except for patients who showed CEA levels exceeding 20 ng/ml. In these patients, the risk of progressive disease increased from 40 to 63% after 12 months of follow-up.
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: Scopus Import
 
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 6 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 05 Jul 2016, 00:48:57 EST by System User